2,3,6-trimethoxy-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)anthracene-1,5,9,10-tetraol

ID: ALA1084267

PubChem CID: 46889393

Max Phase: Preclinical

Molecular Formula: C23H26O13

Molecular Weight: 510.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(O)c3c(O)c(OC)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc3c(O)c2c(O)c1OC

Standard InChI:  InChI=1S/C23H26O13/c1-32-9-4-7-12(17(28)21(9)33-2)15(26)8-5-10(22(34-3)18(29)13(8)14(7)25)35-23-20(31)19(30)16(27)11(6-24)36-23/h4-5,11,16,19-20,23-31H,6H2,1-3H3/t11-,16-,19+,20-,23-/m1/s1

Standard InChI Key:  XTBAYGSBRHXLPU-PHVGODQESA-N

Molfile:  

     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   11.8574  -16.6965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8574  -17.5251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5711  -17.9372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5711  -16.2799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2893  -16.6965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2858  -17.5251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9977  -17.9401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0047  -16.2829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7212  -16.7026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7142  -17.5297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4230  -17.9470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1435  -17.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1504  -16.7147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4371  -16.2928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1427  -16.2862    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1408  -15.4621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1437  -17.9372    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4300  -17.5251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5709  -18.7612    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0070  -15.4588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9945  -18.7642    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4429  -15.4687    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8680  -16.3094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5777  -16.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8530  -17.9608    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8449  -18.7849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1251  -19.1866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1151  -20.0070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8227  -20.4299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5423  -20.0261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5540  -19.1995    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4171  -18.7651    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3959  -20.4093    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8115  -21.2539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2504  -20.4476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2394  -21.2716    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2 17  1  0
  7 10  1  0
 17 18  1  0
  9  8  1  0
  3 19  1  0
  9 10  2  0
  8 20  1  0
  3  6  1  0
  7 21  1  0
  5  4  1  0
 14 22  1  0
  5  6  1  0
 13 23  1  0
 23 24  1  0
  1  2  1  0
 12 25  1  0
  1  4  2  0
 26 25  1  6
 26 27  1  0
  9 14  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  2  3  2  0
 27 32  1  1
  1 15  1  0
 28 33  1  6
  5  8  2  0
 29 34  1  1
 15 16  1  0
 30 35  1  6
  6  7  2  0
 35 36  1  0
M  END

Associated Targets(non-human)

MC3T3-E1 (421 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.45Molecular Weight (Monoisotopic): 510.1373AlogP: 0.02#Rotatable Bonds: 6
Polar Surface Area: 207.99Molecular Species: NEUTRALHBA: 13HBD: 8
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.36CX Basic pKa: CX LogP: -0.31CX LogD: -0.35
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.16Np Likeness Score: 1.56

References

1. Allen JG, Fotsch C, Babij P..  (2010)  Emerging targets in osteoporosis disease modification.,  53  (11): [PMID:20218623] [10.1021/jm9018756]

Source